Curcumin intracellular targets

Curcumin intracellular targets refer to the extensive and diverse array of molecular entities and signaling pathways modulated by curcumin, a natural polyphenolic compound derived from the rhizome of turmeric (Curcuma longa) (NIH, PMC3535097). Unlike traditional pharmacological agents that typically target a single receptor or enzyme, curcumin is characterized by its pleiotropic nature, interacting with a wide variety of proteins including transcription factors (e.g., NF-κB, STAT3, Nrf2), enzymes (e.g., COX-2, iNOS, LOX), and protein kinases (e.g., Akt, MAPK, PKC) (NIH, PMC5666857; MDPI, 10.3390/ijms13033959). These interactions allow curcumin to regulate fundamental cellular processes such as inflammation, oxidative stress, cell cycle progression, and apoptosis. By downregulating pro-inflammatory cytokines and upregulating antioxidant defenses, curcumin has demonstrated potential in the prevention and treatment of various chronic diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions (NIH, PMC3535097). However, its clinical application is significantly hampered by its poor pharmacokinetic profile, characterized by low absorption and rapid metabolism, which necessitates the development of advanced delivery systems like nanoformulations to achieve therapeutic concentrations (NIH, PMC5666857).

Other names

Molecular targets of curcuminPleiotropic targets of curcuminCurcumin-binding proteins

Curcumin exerts its effects through the pleiotropic modulation of multiple signaling pathways, including the inhibition of NF-κB and STAT3 transcription factors, suppression of pro-inflammatory enzymes like COX-2 and 5-LOX, and activation of the Nrf2-mediated antioxidant response (NIH, PMC3535097; NIH, PMC5666857).